金石亚药(300434.SZ)发布前三季度业绩，归母净利润9676.59万元，增长66.47%

Core Insights - The company reported a revenue of 707 million yuan for the first three quarters of 2025, representing a year-on-year decrease of 6.37% [1] - The net profit attributable to shareholders increased to 96.77 million yuan, showing a significant year-on-year growth of 66.47% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 79.01 million yuan, reflecting a year-on-year increase of 51.82% [1] - The basic earnings per share stood at 0.24 yuan [1]